Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment

Dow Jones

23 Dec 2024

By Denny Jacob

Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu.

Shares jumped to $9.16. The stock is down 73% on the year.

The clinical-stage biopharmaceutical company said current topline data from a Phase 1 trial showed that a single dose of the treatment maintained plasma drug levels consistently above EC(90) for more than 23 days with higher dose dating coming.

"This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza," said Chief Science Officer C. David Pauza.

Bird flu is once again an issue to watch. California last week declared a state of emergency due to an increased number of H5N1 bird flu cases that have been detected in the state's dairy cows.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

December 23, 2024 08:28 ET (13:28 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2493757059"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2493757059\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2493757059?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-23 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493757059","market":"hk","top_or_hot":-1,"title":"Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Denny Jacob \n</p>\n<p>\n  Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu. \n</p>\n<p>\n  Shares jumped to $9.16. The stock is down 73% on the year. \n</p>\n<p>\n  The clinical-stage biopharmaceutical company said current topline data from a Phase 1 trial showed that a single dose of the treatment maintained plasma drug levels consistently above EC(90) for more than 23 days with higher dose dating coming. \n</p>\n<p>\n  \"This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza,\" said Chief Science Officer C. David Pauza. \n</p>\n<p>\n  Bird flu is once again an issue to watch. California last week declared a state of emergency due to an increased number of H5N1 bird flu cases that have been detected in the state's dairy cows. \n</p>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 23, 2024 08:28 ET (13:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTraws Pharma Shares Surge 83% on Development of Bird Flu Treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-23 21:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Denny Jacob \n</p>\n<p>\n  Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu. \n</p>\n<p>\n  Shares jumped to $9.16. The stock is down 73% on the year. \n</p>\n<p>\n  The clinical-stage biopharmaceutical company said current topline data from a Phase 1 trial showed that a single dose of the treatment maintained plasma drug levels consistently above EC(90) for more than 23 days with higher dose dating coming. \n</p>\n<p>\n  \"This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza,\" said Chief Science Officer C. David Pauza. \n</p>\n<p>\n  Bird flu is once again an issue to watch. California last week declared a state of emergency due to an increased number of H5N1 bird flu cases that have been detected in the state's dairy cows. \n</p>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 23, 2024 08:28 ET (13:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRAW","symbol_name":"TRAWS PHARMA","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2493757059","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493757059","pubTimestamp":1734960480,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu.Shares jumped to $9.16. The stock is down 73% on the year.The clinical-stage biopharmaceutical company said current topline data from a Phase 1 trial showed that a single dose of the treatment maintained plasma drug levels consistently above EC for more than 23 days with higher dose dating coming.\"This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza,\" said Chief Science Officer C. David Pauza.Bird flu is once again an issue to watch. California last week declared a state of emergency due to an increased number of H5N1 bird flu cases that have been detected in the state's dairy cows.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TRAW":"TRAWS PHARMA","BK4007":"制药"},"translate_title":"Traws Pharma股价因禽流感治疗方法的开发而飙升83%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRAW":0.9},"content_text":"By Denny Jacob \n\n\n  Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu. \n\n\n  Shares jumped to $9.16. The stock is down 73% on the year. \n\n\n  The clinical-stage biopharmaceutical company said current topline data from a Phase 1 trial showed that a single dose of the treatment maintained plasma drug levels consistently above EC(90) for more than 23 days with higher dose dating coming. \n\n\n  \"This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza,\" said Chief Science Officer C. David Pauza. \n\n\n  Bird flu is once again an issue to watch. California last week declared a state of emergency due to an increased number of H5N1 bird flu cases that have been detected in the state's dairy cows. \n\n\n  Write to Denny Jacob at denny.jacob@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 23, 2024 08:28 ET (13:28 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}